AMO unveils new silicone Tecnis IOL

Article

Advanced Medical Optics (AMO) announced the launch of the Tecnis CL intraocular lens (IOL) at the XXIV congress of the ESCRS.

Advanced Medical Optics (AMO) announced the launch of the Tecnis CL intraocular lens (IOL) at the XXIV congress of the ESCRS.

The new lens features blue modified C PMMA haptics for improved visibility and easier implantation, frosted OptiEdge design for reduced edge glare and reduced posterior capsule opacification and highly biocompatible silicone. The Tecnis CL can be implanted using the UNFOLDER Silver Series Implantation Systems and the Silver Advanced Cartridge through a 2.8 mm incision.

The new lens acts as a permanent replacement to the Z9000 and Z9001 Tecnis silicone IOL models.

In August of this year, the US Centers for Medicare and Medicaid Services (CMS) extended New Technology Intraocular Lens (NTIOL) status to the lens. Tecnis and Tecnis CL are the only FDA approved IOLs that are indicated for reducing spherical equivalent, improving visual function and improving night driving performance.

The Tecnis CL is now available in Europe and AMO intends to start shipping the lens to the US, Canada and Asia Pacific within the next month and to Japan by mid-2007.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.